PRESS RELEASE published on 08/08/2023 at 08:00, 1 year 3 months ago Delignit AG continues its positive development in the first half of 2023
PRESS RELEASE published on 07/12/2023 at 20:39, 1 year 4 months ago EQS-Adhoc: Delignit AG: Capital increase placed in full with an issue volume of EUR 8 million
PRESS RELEASE published on 06/20/2023 at 22:56, 1 year 5 months ago EQS-Adhoc: Delignit AG resolves capital increase with subscription rights
PRESS RELEASE published on 03/31/2023 at 07:35, 1 year 7 months ago Delignit AG proposes dividend of 5 cents per share and anticipates considerable growth in fiscal 2023 with profitability remaining unchanged
PRESS RELEASE published on 03/07/2023 at 09:29, 1 year 8 months ago EQS-Adhoc: Delignit AG achieves EBITDA margin of 8.7 % und thus exceeds earnings guidance for fiscal year 2022
Published on 11/21/2024 at 13:30, 24 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 24 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 54 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 54 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 54 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 18 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 38 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
